| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/07/2007 | US7253255 Polypeptide encoded by a nucleic acid underexpressed in esophageal tumor and melanoma |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7253008 Substrate containing at least one polymer having at least one reactive ion etched surface upon which at least one specific binding agent is immobilized; for assaying or isolating analytes in a sample |
| 08/07/2007 | US7252994 Human DR4 antibodies and uses thereof |
| 08/07/2007 | US7252991 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells |
| 08/07/2007 | US7252984 La Sota strain of the virus having a mutation in the gene sequences coding for HN and/or F glycoprotein(s): genetic engineering; also administrable post-hatch; birds; poultry; veterinary medicine; infectious bronchitis and bursal disease; adenovirus, reovirus, pox diseases; laryngotracheitis; influenza |
| 08/07/2007 | US7252974 Human growth gene and short stature gene region |
| 08/07/2007 | US7252969 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 08/07/2007 | US7252968 Deregulated chromatin-regulator genes that have a SET domain encoding specific proteins having a stop codon that shortens the protein by 47 C-terminal amino acids; for use in diagnosis and therapy of cancer |
| 08/07/2007 | US7252957 Identification of etiology of autism |
| 08/07/2007 | US7252956 Antibodies to human Ependymin |
| 08/07/2007 | US7252954 Sets of digital antibodies directed against short epitopes, and methods using same |
| 08/07/2007 | US7252929 Methods for identifying alpha PDGFR agonists and antagonists |
| 08/07/2007 | US7252827 Fusion protein comprising an immunogenic polypeptide; treatment of Hepatitis CVirus infection and assays for the diagnosis of HCV |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | US7252823 Recombinant A2-specific TNFα-specific antibodies |
| 08/07/2007 | US7252822 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist |
| 08/07/2007 | US7252821 Cancerous disease modifying antibodies |
| 08/07/2007 | CA2381770C Human ctla-4 antibodies and their uses |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2252374C A process for viral inactivation of lyophilized blood proteins |
| 08/07/2007 | CA2183079C Method for preparing a multicombinatorial library of antibody gene expression vectors |
| 08/07/2007 | CA2115565C Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 08/07/2007 | CA2062829C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 08/02/2007 | WO2007087412A2 Tat-036 and methods of assessing and treating cancer |
| 08/02/2007 | WO2007087370A2 Tat-038 and methods of assessing and treating cancer |
| 08/02/2007 | WO2007087289A2 Anti-fcrn antibodies for treatement of auto/allo immune conditions |
| 08/02/2007 | WO2007087013A2 Functional immunoassay |
| 08/02/2007 | WO2007086994A1 Single chain fragment of monoclonal antibody 9b9 and uses thereof |
| 08/02/2007 | WO2007086619A1 Modified glycoprotein having unsaturated functional group |
| 08/02/2007 | WO2007086526A1 Gene polymorphism and use thereof |
| 08/02/2007 | WO2007085837A1 Binding molecules |
| 08/02/2007 | WO2007085815A2 Ligands that bind il-4 and/or il-13 |
| 08/02/2007 | WO2007085814A1 Fusion proteins that contain natural junctions |
| 08/02/2007 | WO2007085567A2 Synergistic compositions for treating hiv |
| 08/02/2007 | WO2007085470A2 Cd19-specific immunotoxin and treatment method |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2007067984A3 Neutralizing antibodies against primate psgl-1 and uses therefor |
| 08/02/2007 | WO2007065151A3 Differential immunoassay for prrs vaccine antibody |
| 08/02/2007 | WO2007059300A3 Anti-alk antagonist and agonist antibodies and uses thereof |
| 08/02/2007 | WO2007053176A3 Method of protecting against staphylococcal infection |
| 08/02/2007 | WO2007052067A3 Von willebrand factor (vwf) binding peptides |
| 08/02/2007 | WO2007045927A3 Therapeutic agent |
| 08/02/2007 | WO2007040653A3 Anti-cd30 antibodies that bind to intact cd30 but not soluble cd30 |
| 08/02/2007 | WO2007036745A3 Interleukin-13 antibody composition |
| 08/02/2007 | WO2007027321A3 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases |
| 08/02/2007 | WO2007019620A8 Engineered antibodies with new world primate framework regions |
| 08/02/2007 | WO2007008712A3 Anti-alpha v beta 6 antibodies and uses thereof |
| 08/02/2007 | WO2006084129A3 Genes of porphyromonas gingivalis w83 involved in invasion of human cells |
| 08/02/2007 | WO2006078766A3 Methods and compositions for metastatic tumor screening |
| 08/02/2007 | WO2006068953A3 Antibodies directed to angiopoietin-2 and uses thereof |
| 08/02/2007 | WO2006068867A9 Combination therapy for b cell disorders |
| 08/02/2007 | WO2005089505A3 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 08/02/2007 | WO2005084329A3 Method for inhibiting tumor formation and growth |
| 08/02/2007 | WO2005019264A3 Human lxr alpha variants |
| 08/02/2007 | WO2004091519A3 Methods of preventing or treating respiratory conditions |
| 08/02/2007 | WO2004058044A3 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 08/02/2007 | WO2002062964A3 Ap1 amine oxidase variants |
| 08/02/2007 | US20070180546 Production of a transgenic avian by cytoplasmic injection |
| 08/02/2007 | US20070179281 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | US20070179278 HIV fusion inhibitor peptides with improved biological properties |
| 08/02/2007 | US20070179086 Polypeptides and antibodies |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178552 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/02/2007 | US20070178551 Methods for producing modified glycoproteins |
| 08/02/2007 | US20070178544 Anti fk778antibodies and high sensitive immunoassay methods |
| 08/02/2007 | US20070178540 Goodpasture antigen binding protein |
| 08/02/2007 | US20070178539 Novel Cytokine Receptors and Nucleic Acids Encoding the Same |
| 08/02/2007 | US20070178537 Assays for detection of bioactive compounds that interact with heat shock protein 90 |
| 08/02/2007 | US20070178531 Rabbit monoclonal antibodies against mouse/human Id3 proteins |
| 08/02/2007 | US20070178528 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 08/02/2007 | US20070178524 Methods for determining and lowering caffeine concentration in fluids |
| 08/02/2007 | US20070178522 Gold-binding protein and use thereof |
| 08/02/2007 | US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential |
| 08/02/2007 | US20070178492 Human tumor necrosis factor receptor polynucleotides |
| 08/02/2007 | US20070178491 Compositions and Methods for Synthesizing Nucleic Acids |
| 08/02/2007 | US20070178486 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 08/02/2007 | US20070178484 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders |
| 08/02/2007 | US20070178462 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof |
| 08/02/2007 | US20070178117 chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types associated with mammalian Borrelia infections; vaccine and diagnostic for Lyme disease |
| 08/02/2007 | US20070178114 Novel kallikrein gene |
| 08/02/2007 | US20070178112 Immunoglobulins; immunogens |
| 08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
| 08/02/2007 | US20070178106 Compositions and methods for enhancing nk cell activity |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178103 CD19-specific immunotoxin and treatment method |
| 08/02/2007 | US20070178101 Ovr110 antibody compositions and methods of use |
| 08/02/2007 | US20070178100 genetically engineered T. cruzi wherein the amastigote stage-regulated protein is expressed from a gene involved in energy metabolism; suitable for use in diagnosis of Chagas disease, in drug development, in antibody production, and in the production of vaccines, including live vaccines |
| 08/02/2007 | US20070178099 Suppression of TNFalpha and IL-12 in therapy |
| 08/02/2007 | US20070178098 Interleukin-6 antagonists |
| 08/02/2007 | US20070178097 Interleukin-10 antibodies |
| 08/02/2007 | US20070178096 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 08/02/2007 | US20070178095 Anti-myostatin antibodies |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178093 Lymphocytes; methods |
| 08/02/2007 | US20070178092 Humanized anti-CD3 specific antibodies |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178089 Mucosal vascular addressins and uses thereof |
| 08/02/2007 | US20070178088 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |